Clinical trial
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
NCT07454642
Study timeline
Study start (actual)2026-03-31Date precision: day
Registry last updated2026-10-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Vulvar Adenocarcinomaunresolved
PDAC - Pancreatic Ductal Adenocarcinomaunresolved
Gastric Adenocarcinomaunresolved
GEJ Adenocarcinomaunresolved
Cervical Adenocarcinomaunresolved
Cervical Adenosquamous Carcinomaunresolved
Small Cell Carcinoma of Lungunresolved
Colorectal Cancerunresolved
Interventions
AVA6103DRUG
Sponsors & collaborators
Avacta Life Sciences Ltdlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07454642 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.